Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood 2020-11, Vol.136 (19), p.2229-2232
Hauptverfasser:	Lurain, Kathryn, Uldrick, Thomas S., Ramaswami, Ramya, Polizzotto, Mark N., Goncalves, Priscila H., Widell, Anaida, Steinberg, Seth M., Jaffe, Elaine S., Pittaluga, Stefania, Wang, Hao-Wei, Yuan, Constance M., Tamula, Mary Anne, Martin, Staci, Wolters, Pamela L., George, Jomy, Little, Richard F., Yarchoan, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - therapeutic use Antiretroviral Therapy, Highly Active - methods Central Nervous System Neoplasms - drug therapy Central Nervous System Neoplasms - pathology Central Nervous System Neoplasms - virology Drug Therapy, Combination Female Follow-Up Studies HIV - isolation & purification HIV Infections - complications HIV Infections - drug therapy HIV Infections - virology Humans Letter to Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - pathology Lymphoma, Non-Hodgkin - virology Male Methotrexate - administration & dosage Middle Aged Prognosis Prospective Studies Rituximab - administration & dosage Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!